一月 2026
- Home
- CompuGroup Medical SE & Co. KGaA
一月 2026的CompuGroup Medical SE & ...市场份额分析
CompuGroup Medical SE & Co. KGaA is a publicly listed software company based in Koblenz that develops and offers software for the healthcare sector.
CompuGroup Medical SE & Co. KGaA(包含公司地区分支机构)
查看更多网站流量和参与度信息- cgm.com
CompuGroup Medical SE & Co. KGaA收入截至 一月 2026为 > 1B
CompuGroup Medical SE & Co. KGaA主要域名产生的收入
3 年中CompuGroup Medical SE & Co. KGaA主要域名的收入
CompuGroup Medical SE & Co. KGaA主要域名的收入
CompuGroup Medical SE & Co. KGaA热门域名的总访问量
了解CompuGroup Medical SE & Co. KGaA市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
CompuGroup Medical SE & Co. KGaA热门域名的平均访问时长
分析CompuGroup Medical SE & Co. KGaA参与度指标。
过去 3 个月的平均访问时长
子公司明细
CompuGroup Medical SE & Co. KGaA热门域名的平均页面浏览量
了解CompuGroup Medical SE & Co. KGaA如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
CompuGroup Medical SE & Co. KGaA 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻CompuGroup Medical partners with CVC Capital Partners.CompuGroup Medical, a well-known name in digital healthcare, has partnered with CVC Capital Partners in a deal that has made headlines in the e-health industry.
十二月 17, 2024阅读更多
新闻CompuGroup Medical hired Benedikt Brueckle as Chief Executive Officer for the US on Jan 1st '25.AUSTIN, Texas, March 27, 2024 /PRNewswire/ - Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025.
三月 26, 2024阅读更多
新闻CompuGroup Medical acquired Medicuslis on Dec 15th '22.CompuGroup Medical on Thursday announced that it is broadening its U.S. presence with the acquisition for an undisclosed amount of Medicus Laboratory Information Systems (Medicus) from Diagnostic Systems Consulting, a developer of laboratory information systems with headquarters in Weston, FL.
十二月 8, 2022阅读更多
查看 CompuGroup Medical SE & Co. KGaA 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。